ArticleBMC gastroenterology2026

Inhibition of TLR4 enhances oxaliplatin chemotherapy sensitivity in esophageal squamous cell carcinoma by suppressing inflammation and glycolysis.

Ziqi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.